Regeneron hopes for full FDA approval of COVID-19 antibody cocktail
The treatment currently has emergency use authorization.
•
Oct 14, 2021, 4:54 PM
•
Updated 1,163 days ago
Share:
More Stories
0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
103ds ago
Hometown Heroes in the Hudson Valley
150ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
294ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
315ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
442ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
442ds ago0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
103ds agoHometown Heroes in the Hudson Valley
150ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
294ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
315ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
442ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
442ds agoA new medicine to treat COVID-19 could be on the way as the Food and Drug Administration has started its review of 's COVID-19 antibody cocktail.
The Tarrytown-based biotech company says the FDA accepted its priority review application and they are hoping to receive full approval
The treatment currently has emergency use authorization.
Regeneron wants full approval to treat patients infected with the virus who are not in the hospital.
More from News 12
2:06
STORM WATCH: Morning snow showers followed by partly cloudy skies in the Hudson Valley
1:30
Thunderbolt 12: Wet roads during busy holiday travel weekend in Westchester
1:01
Caught on camera: Yonkers family says mother's mail was stolen from porch mailbox
1:43
Holiday travel rush begins in Westchester County
1:03
Winter solstice marks official start to astronomical winter on Saturday
1:51
